LUCIUS 卢修斯 贝舒地尔 Belumosudil慢性移植物 抗宿主病

贝舒地尔

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Belumosudil

老挝国家食药监局批准上市
老挝国家药检所检测认证

Rx Only

慢性移植物

Each film-coated tablet contains
Belumosudil mesvlate 242.5mg equrvalent
to Belumosudil.

Indication:

LuciBelu

抗宿主病

LuciBelu is a kiase inhibitor indicated for
the treatment of adult and pediatric patients
12 years and older with chronie graft-versus
host disease (chronic GVHD) after failura of

Belumosudil Tablets

at least two prior lines of systemic therapy
Dasasaand

Dosage and Use:py.

Recommended Dosage: 200 mg taken orallv

200mg

once daily with food.

FDA批准

Storage: in a dry place and store at 20℃ to
25C.
Warning:
Keep medicine out of reach of Children.
Do not administer LuciBe lu during
Pregnancy and Lactation.
PLEASESEE PACKAGE INSERT
Manufactured and Marketed by;
LUCIUS

权威认证

Vientiane Capital, Laos
age, Aaytnany districi,

30

Tablets

Warning: To be sold by retail on prescripti
eastered physicians only, and as direet

LUCIUS

PHARMACEUTICALS

口碑质量

适应症:
适用于12岁及以上的成人和儿童慢性移植物抗宿

主病(慢性GVHD)患者在至少两种既往全身治疗失
败后的治疗。
推荐剂量:
1 、 口 服 给 药 , 每 次 200mg, 每 日 一
2、整片吞下,随食物服用。